Opus Genetics (IRD) Capital Expenditures (QoQ) (2010 - 2019)
Opus Genetics (IRD) Capital Expenditures (QoQ) (2010 - 2019) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Opus Genetics |
355.39 Mn |
295.43 Mn |
- |
| Date | Value |
|---|
| Jun 30, 2019 |
-52.95% |
| Sep 30, 2018 |
3,572.25% |
| Jun 30, 2018 |
-61.39% |
| Mar 31, 2018 |
-95.32% |
| Dec 31, 2017 |
1,455.33% |
| Sep 30, 2017 |
-75.20% |
| Jun 30, 2017 |
251.70% |
| Mar 31, 2017 |
883.87% |
| Dec 31, 2016 |
-46.41% |
| Sep 30, 2016 |
-74.20% |
| Jun 30, 2016 |
-36.58% |
| Mar 31, 2016 |
-53.12% |
| Dec 31, 2015 |
-75.56% |
| Sep 30, 2015 |
800.76% |
| Jun 30, 2015 |
-43.88% |
| Mar 31, 2015 |
-28.48% |
| Dec 31, 2014 |
-30.40% |
| Sep 30, 2014 |
52.64% |
| Jun 30, 2014 |
176.93% |
| Mar 31, 2014 |
2.20% |
